Researchers decipher critical features of a protein behind ALS
The Sigma-1 receptor (S1R) is a transmembrane protein with important roles in stabilizing cellular functions in both normal physiology and disease. Especially in neurodegenerative diseases, S1R's activity has been shown to provide neuronal protection by stabilizing the cell environment (based on the movement of calcium ions), improving mitochondrial function and reducing a damaging cellular stress caused by the diseases, called endoplasmic reticulum stress. Drugs are now being developed to try to boost these cell protective S1R activities in several diseases.
S1R missense mutations are one of the causes of distal hereditary motor neuronopathies and amyotrophic lateral sclerosis (also known as Lou Gehrig’s disease). ALS is the ailment that afflicted renown late physicist Stephen Hawking. Yet, even though S1R has been studied intensively, basic aspects remained controversial, such as S1R topology and whether it reaches the cell membrane.
A new study led by Tel-Aviv University researcher Gerardo Lederkremer from the Shmunis School of Biomedicine and Cancer Research and Sagol School of Neuroscience, together with Nir Ben Tal from the School of Neurobiology, Biochemistry and Biophysics, and students in their labs, sheds light on some of these important questions. The study was recently published in the Journal of Biological Chemistry.
“Proteins, much like a bipolar magnet, have two ends — carboxy (-COOH group) and amino (-NH2 group)," said Lederkremer. "In one trial, we tagged the carboxy end (C-terminal tagging) and found that the protein is set in a specific orientation on internal membranes of the cell, where the amino end faces the cytoplasm. In another approach, we tagged the amino end and found equal probability for both possible orientations.”
These findings provide an explanation for current contradictions in the literature regarding the favored orientation, as the tagging itself affects the receptor’s topology — “an act of observation which affects the observed system.” Therefore, said Lederkremer, “we applied other approaches, called protease protection assay and glycosylation mapping, which showed incontrovertibly that S1R assembles so that the amino end faces the cytoplasm. Moreover, using additional approaches we found that the receptor is retained in the ER and hardly exits to the cell surface. This finding explains how the S1R functions in the ER and reduces the pathogenic ER stress”.
Lederkremer said he is optimistic about the new findings: “Having deciphered a crucial mechanism in the receptor's function, we have no doubt that our new findings can affect therapeutic approaches based on S1R, and hopefully alleviate the suffering of neurodegenerative patients, especially those with ALS. In this field every small step is a significant advance.”
This article was reprinted with permission from Tel Aviv University. Read the original.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
![The quest to treat and cure xerostomia](/getmedia/09045019-5c58-4434-9eb0-d6be609842cb/Xerostomia-thumb.jpg?width=480&height=270&ext=.jpg)
The quest to treat and cure xerostomia
Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.
![There's more to blue cheese than just the stench](/getmedia/65d1751a-27b4-405b-9210-8cde34249ef5/More-to-blue-cheese-480x270.jpg?width=480&height=270&ext=.jpg)
There's more to blue cheese than just the stench
Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.
![Engineering cells to broadcast their behavior can help scientists study their inner workings](/getmedia/a5c8da38-1a39-4183-be72-85d5cbff8a29/Engeneering-cells-to-broadcast-480x270.jpg?width=480&height=270&ext=.jpg)
Engineering cells to broadcast their behavior can help scientists study their inner workings
Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.
![From the journals: JBC](/getmedia/a3620094-c80e-41b9-91ab-22037b087112/FTJ-JBC-07-19-24-480x270.jpg?width=480&height=270&ext=.jpg)
From the journals: JBC
Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.
![Seeking the sweet spot to beat a pig parasite](/getmedia/30869767-881b-438b-9f19-531ef9eee79e/Pig-parasite-480x270.jpg?width=480&height=270&ext=.jpg)
Seeking the sweet spot to beat a pig parasite
Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.
![Radioactive drugs strike cancer with precision](/getmedia/f3a6418b-340a-43cc-b53f-30916dbbd8f4/Radioactive-drugs-strike-cancer-480x270.jpg?width=480&height=270&ext=.jpg)
Radioactive drugs strike cancer with precision
The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.